3
ICAP

IMPOWER-022: The Merck Study (on hold)

IMPOWER-022: The Merck Study (on hold)Districts (or national)Bronx

Project Details

A randomized, active-controlled, double-blind clinical study to investigate the safety and efficacy of oral Islatravir, a once-monthly pill as preexposure prophylaxis (PrEP) in cisgender women at high risk for HIV-1 infection Soon to begin enrollment Web Links: https://clinicaltrials.gov/ct2/show/NCT04644029